CbdMD, Inc.
YCBD
Rank in Stocks
#30814
cbdMD, Inc. is engaged in the production and distribution of a diverse array of... cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
Share Price
$0.381
Last synced: 2026-11-09
Market Cap
$4.27M
Change (1 day)
-8.41%
Change (1 year)
-40.65%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CbdMD, Inc. (YCBD)
Category
Healthcare
EPS for CbdMD, Inc. (YCBD)
EPS as of June 2026 TTM: $-0.31
According to CbdMD, Inc.'s latest financial reports, its current EPS (TTM) is $-0.31. At the end of 2025 the company had an EPS of $-1.09, an increase over its 2024 EPS of $-1.79.
EPS history for CbdMD, Inc. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.31 | -71.56% |
| 2025 | $-1.09 | -39.11% |
| 2024 | $-1.79 | -86.56% |
| 2023 | $-13.32 | -76.13% |
| 2022 | $-55.80 | 191.23% |
| 2021 | $-19.16 | -253.65% |
| 2020 | $12.47 | -110.91% |
| 2019 | $-114.29 | 4,682.01% |
| 2018 | $-2.39 | -77.11% |
| 2017 | $-10.44 | -71.46% |
| 2016 | $-36.58 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -2,197.23% |
DE
|
|
| $6.08 | -2,060.52% |
DE
|
|
| $1.55 | -600.19% |
JP
|
|
| $3.66 | -1,280.65% |
CH
|
|
| $0.45 | -245.16% |
IL
|
Questions about CbdMD, Inc.'s earnings per share (EPS)
What is CbdMD, Inc.'s earnings per share (EPS)?
CbdMD, Inc.'s earnings per share (EPS) over the last twelve months is $-0.31, as of Jun 2026.
What was CbdMD, Inc.'s earnings per share (EPS) in 2025?
In 2025, CbdMD, Inc.'s earnings per share (EPS) was $-1.09, compared with $-1.79 in 2024.
How has CbdMD, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, CbdMD, Inc.'s earnings per share (EPS) was highest in 2020 ($12.47) and lowest in 2022 ($-55.80).
How does CbdMD, Inc.'s earnings per share (EPS) compare with similar companies?
CbdMD, Inc.'s earnings per share (EPS) ($-0.31) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.